Trade

KOBO Biotech share price

High risk
  • 58%Low risk
  • 58%Moderate risk
  • 58%Balanced risk
  • 58%High risk
  • 58%Extreme risk
  • 2.37(4.41%)
    December 16, 2025 15:47:45 PM IST
    • NSE
    • BSE
  • Vol : 5.16 K (NSE + BSE)
    Last 20 day avg : 20.91 K

KOBO Biotech is trading 4.41% upper at Rs 2.37 as compared to its last closing price. KOBO Biotech has been trading in the price range of 2.37 & 2.27. KOBO Biotech has given -47.70% in this year & 3.18% in the last 5 days. The company posted a net profit of -1.33 Crores in its last quarter.Listed peers of KOBO Biotech include Cipla (-0.48%), Torrent Pharmaceuticals (-0.79%), Dr Reddy's Laboratories (-0.11%).The Mutual Fund holding in KOBO Biotech was at -% in . The MF holding has - from the last quarter. The FII holding in KOBO Biotech was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 16, 2025, 07:15 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.31
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
2.27
Highest
2.37
52 week range
Lowest
1.99
Highest
4.56
KOBO Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Cipla
Bearish
1,500.00-0.481,21,165.6922.873.860.870.81
Torrent Pharmaceuticals
Neutral
3,751.05-0.791,26,577.5466.6216.920.8417.62
Dr Reddy's Laboratories
Bullish
1,279.00-0.111,06,994.9218.413.10.642.34
Sun Pharmaceutical Industries
Neutral
1,782.80-0.804,28,470.1437.265.930.900.50
Divi's Laboratories
Neutral
6,341.00-0.091,68,437.1376.1611.160.480.01
KOBO Biotech Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2024-08-14Quarterly Results
2024-05-30Audited Results
2024-02-14Quarterly Results
2023-11-10Quarterly Results
2023-08-11Quarterly Results
About the company KOBO Biotech
  • IndustryBiotechnology & Drugs
  • ISININE881A01015
  • BSE Code531541
  • NSE Code
Kobo Biotech Limited is an India-based company. The Company's business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company is in the corporate insolvency resolution process.
  • Management Info
  • Ajit KamathNon-Executive Chairman of the Board, Managing Director
KOBO Biotech Share Price FAQs

KOBO Biotech is trading at 2.37 as on Tue Dec 16 2025 10:17:45. This is 4.41% upper as compared to its previous closing price of 2.27.

The market capitalization of KOBO Biotech is 5.88 Cr as on Tue Dec 16 2025 10:17:45.

The 52 wk high for KOBO Biotech is 4.56 whereas the 52 wk low is 1.99

KOBO Biotech can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 28.49
  • Dividend Yield: 0.00%
  • D/E ratio: -

KOBO Biotech reported a net profit of -4.93 Cr in 2024.